Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
68,100
-1,300 (-1.87%)
At close: Oct 2, 2025
-1.87%
Market Cap553.44B
Revenue (ttm)12.16B
Net Income (ttm)2.57B
Shares Out8.13M
EPS (ttm)-273.00
PE Ratio214.98
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume68,725
Average Volume130,040
Open69,900
Previous Close69,400
Day's Range67,500 - 70,200
52-Week Range27,250 - 86,500
Betan/a
RSI47.30
Earnings Daten/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.